These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2145083)

  • 1. [Seroconversion following immunization with a plasma-derived vaccine against hepatitis B: study of a 3-injection protocol (0, 1, 6 months) in Brazzaville (Congo)].
    Taty-Taty R; Saliou P; Yala F; Couroucé AM; Arthaud ML; Nerelli B; Biendo M; Wassoumbou E
    Bull Soc Pathol Exot; 1990; 83(2):155-8. PubMed ID: 2145083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenicity of the vaccine against hepatitis B virus in schoolchildren of Madrid].
    Gil Miguel A; Lasheras Lozano ML; Vizcaino MJ; del Rey Calero J; Martín Hernández D
    Rev Sanid Hig Publica (Madr); 1992; 66(2):149-56. PubMed ID: 1366248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose hepatitis B vaccination in children.
    Milne A; Allwood GK; Pearce NE; Lucas CR; Krugman S
    N Z Med J; 1986 Feb; 99(795):47-9. PubMed ID: 2935755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
    Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenicity and tolerance of a combined hepatitis A/B vaccine. Preliminary results with a candidate vaccine].
    Kallinowski B; Bock HL; Clemens R; Theilmann L
    Dtsch Med Wochenschr; 1995 Oct; 120(42):1426-9. PubMed ID: 7555671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
    Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
    N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Active immunization against hepatitis B].
    Wildgrube HJ; Classen M; von Lohr R; Kurth R; Brede HD
    Dtsch Med Wochenschr; 1984 Feb; 109(7):246-50. PubMed ID: 6230216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
    Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
    Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men.
    Prinsen H; Goilav C; Safary A; André FE; Piot P
    Postgrad Med J; 1987; 63 Suppl 2():147-9. PubMed ID: 3317352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against hepatitis B on the Ivory Coast: study of the anti-HBs response in healthy adult subjects carrying only anti-HBc antibodies before vaccination].
    Ouattara SA; Meite M; Aron Y
    Bull Soc Pathol Exot Filiales; 1986; 79(1):27-38. PubMed ID: 3698152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of immune response to hepatitis B vaccine in Thai blood donors.
    Nuchprayoon C; O-Charoen RO; Vaivanijkul J; Apirakyothin T; Akkawat R; Chumnijarakij T
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):17-21. PubMed ID: 1387972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine.
    Halliday ML; Rankin JG; Bristow NJ; Coates RA; Corey PN; Strickler AC
    Arch Intern Med; 1990 Jun; 150(6):1195-200. PubMed ID: 2141247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults.
    Just M; Berger R; Just V
    Postgrad Med J; 1987; 63 Suppl 2():121-3. PubMed ID: 3317346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.